NASDAQ
VSEE
Last Price
US $0.025
Valuation
Financial
Performance
Cash flow to debt coverage
VSee Health, Inc. cash flow to debt ratio of -141.43% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
VSee Health, Inc.'s free cash flow has increased -40.53% from $-5.84M last year to $-3.48M, signaling increasing performance
Debt-to-equity ratio
VSee Health, Inc.'s debt to equity ratio is 0.34, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
VSee Health, Inc.'s debt has increased relative to shareholder equity from -516.43 last year to 0.34 today, signaling weakened financials
Net debt to EBITDA
VSee Health, Inc. has a net cash position, so leverage is healthy.
Interest coverage
VSee Health, Inc.'s interest coverage ratio is -4.87, which means that the company struggles to meet interest obligations, signaling financial risk.
Profit margin growth
VSee Health, Inc.'s profit margin has increased (-83.32%) in the last year from -553.69% to -92.37%, signaling increasing performance
Current ratio
VSee Health, Inc.'s short-term liabilities of $16.24M exceed its short-term assets of $8.37M, signaling financial risk
Return on assets
VSee Health, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
VSee Health, Inc.'s return on equity of -11.57K%, is lower than 15.00%, indicating bad performance
Earnings quality
VSee Health, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
VSee Health, Inc. has insufficient public price history to evaluate earnings stability.
Positive free cash flow
VSee Health, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
VSee Health, Inc. has negative free cash flow, indicating cash burn
Earnings growth
VSee Health, Inc.'s yearly earnings has increased -74.50% since last year from $-57.70M to $-14.71M, signaling increasing performance
Revenue growth
VSee Health, Inc.'s yearly revenue has increased 40.27% since last year from $10.42M to $14.62M, signaling increasing performance
Return on invested capital
ROIC -111.65% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
VSee Health, Inc.'s 3-year revenue CAGR of 31.85% is positive, indicating growing revenue over the past 3 years
Revenue consistency
VSee Health, Inc. had revenue growth in 3 out of 5 years, indicating consistent revenue performance
Return on equity consistency
VSee Health, Inc. has insufficient public price history to evaluate ROE consistency.
Cash Flow Valuation (DCF)
VSee Health, Inc. has insufficient data to evaluate this check.
Earnings yield (TTM)
VSee Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
VSee Health, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
VSee Health, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
VSee Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
VSee Health, Inc. has a price-to-book ratio of 0.25x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
VSee Health, Inc. has a price-to-sales ratio of 0.11x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-11570.74%
Return on equity
ROIC: -111.65%
Valuation History
-
Price to Earnings
EV/EBITDA: -0.19X
Cash flow
Profit margin
-
Cash flow
-
Fair Value
Market $0.025
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.